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ARTICLE INFO Abstract
Introduction: Gestational Diabetes Mellitus (GDM) is glucose intolerance diagnosed 
for the first time in pregnancy. It may lead to potentially serious short term and long-term complications for both mother and fetus or newborn. 
Material and Methods: Prospective study was conducted at the University clinic for gynecology and obstetrics, Skopje for the period of one year. 100 pregnant women in the second trimester which performed oral glucose tolerance test (75g OGTT) were evaluated. The study included 50 women with GDM and control group of 50 women with negative OGTT at the same gestational age, parity and maternal age. Gestational weight gain, blood pressure and urine analysis for proteinuria were recorded monthly. Patients with GDM were more often followed according to the clinical protocol. Maternal and neonatal data was collected after birth from medical records during discharge from the clinic. The perinatal outcome of pregnant women with or without GDM was analysed. 
Results: There was a significant difference in BMI between the women with GDM and normoglycemic women. Hypertensive disorders of pregnancy, preterm labour and 
delivery by caesarean section were significantly more often in GDM pregnancies vs 
control group. Respiratory distress, hypoglycemia, pH <25, lower Apgar score in the first 
minute and admission in the neonatal intensive care unit was significantly more often in the neonates from mothers with GDM vs controls. 
Conclusion: Many parameters of the perinatal outcome were significantly associated with GDM in our study. Adequate treatment can achieve better maternal and neonatal outcome. 
IntroductionGDM is most often metabolic complication of pregnancy with incidence between 1 and 14% depending of characteristics of the selected population and diagnostic criteria [1]. GDM has increased risk for perinatal morbidity and markedly increased risk for type 2 diabetes. Perinatal risk in GDM is connected to uncontrolled glucose levels and GDM treatment may result in reduction of complications [2]. 
 
Maternal RiskIndependently of birth weight association of caesarean section deliveries in GDM is more than 35% compared to 20% in general population. Diagnosis of GDM alone leads to easier decision for cesarean section delivery [3,4]. GDM increases the risk for premature spontaneous and induced labor. Beigelman et al. showed that prevalence of spontaneous preterm labor was 7% 
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in nondiabetic, 10% in GDM up to 25% in pregestational diabetes [5]. Increased risk for hypertensive disorders of pregnancy in GDM is connected to mutual risk will develop preeclampsia and preeclampsia predispose these women to complications like prematurity and IUGR [3].
Fetal and Neonatal ComplicationsAbnormal fetal growth, chemical imbalance and respiratory distress may result in admission of the newborn in ICU [6]. Fetuses exposed to higher levels of glucose in utero develop hyperinsulinemia, than reduced surfactant production, weak stabilization of alveoli during emporium and development of RDS 
[7]. Macrosomia defined as birth weight ≥4000 g (above 90th percentile for gestational age) may occur in 12% of the newborns in general population and 15-45% of the GDM newborns. Birth weight above 4500g carries 6x greater risk for birth traumatism and 20x greater risk for plexus brachialis injuries [7]. Neonatal hypoglycemia is an expected metabolic disorder, a transient complication in 50% of macrosomia newborns and 5-15% of optimally controlled GDM [8]. Neonatal hyperbilirubinemia is associated complication of polycythemia as a result in immature system for bilirubin conjugation in newborns form GDM mothers. Hyperglycemia affects the organogenesis and leads to increased malformation risk in GDM. GDM women more often have history of early fetal loss and GDM can be the link between spontaneous 
abortions, PCOS and insulin resistance [9]. All forms of diabetes in pregnancy are related to increased risk for stillbirth therefore adequate prenatal care, multidisciplinary approach, ultrasound monitoring, nonstress test and careful assessment for delivery time is needed [10]. 
Material and MethodsProspective longitudinal case control study was made at the University clinic for ob@gyn in Skopje in a 2-year interval. Pregnant women that had prenatal care at the outpatient department in the Clinic in that period were selected. From the ob@gyn specialist in primary, secondary and tertiary levels of care patients were scheduled for GDM screening with 75 g OGTT at the biochemical laboratory at the clinic. Pregnant women with gestational diabetes were selected as investigated group and patients with negative OGTT were in the Control Group (CG). They were with matching gestational age, party and maternal age. Inclusion criteria were: 
maternal age between 18 and 45, eligibility for follow up, first prenatal visit before 20 gestational week, GDM diagnosed by IADPSG criteria with 75g OGTT in the morning after night feast with venous blood drawn 0, 60 and 120 minutes after ingestion of 75g of glucose dissolved in 200 ml of water with reference values: 0 < 5,1, 1-h < 10,0, 2-h < 8,5 mmol/L. 
Exclusion Criteria: were pregestational diabetes, chronic 
hypertension, chronic inflammatory condition, stillbirth, fetal anomalies, noninfectious syndrome. By medical scale body weight and height was measured for all the pregnant women. Body Mass 
Index-BMI was calculated with the formula = weight (kg) /height (m2). Monthly gestational weight gain, blood pressure and urine analyses for proteinuria was noted. Patients were delivered at the University ob@gyn clinic. By a pediatrician 1st and 5th minute Apgar score was estimated (respirations, heartbeat, muscle tonus, 
reflexes and skin color). Each criteria were calculated by 0, 1 or 2 points according to the conditions that was observed. After delivery the umbilical cord was double clamped and blood sample was taken from the umbilical artery for arterial acid base status (Rapid point 405, Siemens). From the newborn babies blood sample for glucose levels (glucose oxidase, Beckman Glucose Analyzer) and bilirubin 
levels (Total Bilirubin assay, ARCHITECT c Systems) was collected according to the pediatrician assessment.
Perinatal DataDetail medical and clinical information on delivery outcome for all mothers and newborns were taken from maternal and neonatal medical records: way of delivery, complications during and after birth, admission of the newborn in ICU, neonatal outcome. a) Composite Maternal Outcome Includes: GWG, gestational weight gain; hypertensive disorders of pregnancy: pregnancy 
induced hypertension, preeclampsia (blood pressure >140/90 mmHg with proteinuria > 0.3 g/24 h or ++ on isolated sample); premature delivery (<37 gestational weeks); caesarean section and intrauterine fetal death. b) Composite Neonatal Outcome Includes: neonatal weight/length ; 1st and 5th minute Apgar score of the newborn; acid-base status of the newborn 5 minutes after birth; neonatal hyperbilirubinemia:>12 mg/dl; clinical and biochemical neonatal hypoglycemia: 2 or more neonatal glycemia below value of 2.6 mmol/l; neonatal Respiratory Distress Syndrome (RDS): need of at least 4 hours respiratory support by supplemental oxygen), transitional tachypnea of the newborn. 
Study was approved by Ethical committee and all subjects have 
confirmed informative consent.
Statistical analysisa) Data was analysed with statistical computer programme SPSS 23 for Windows. b) numeric data was given with descriptive statistics (standard deviation, median and interquartile interval).c) qualitative data was shown in absolute and relative values.d) for comparison of analysed groups nondependent parametric and nonparametric tests were used. (Student t-test 
for independent samples, Chi-square тест, Fisher exact тест, 
Mann-Whitney тест).
e) for all analyses р value < 0,05 was taken as statistically 
significant.
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f) Data on perinatal outcome was taken from the medical records on discharge form the clinic.
ResultsOne hundred pregnant women which had an OGTT in the biochemical laboratory at the University clinic for ob@gyn were included in the study and divided into 2 groups (Figure 1): a) Gestational diabetes Melitus or investigated group, n= 50 womenb) Control group with negative OGTT, n= 50 women
Figure 1: The pregnant women were treated with diet 
(n=34, 68%), insulin therapy (n=14, 28%) and 2 women had 
metformin (n=2, 4%).
Body Mass Index (Bmi) In Gdm and Normoglycemic 
WomenThe body mass index had values between 18.7 and 48 in the GDM group and between 21 and 41 in the control group. Average value of BMI was 31.01 ± 7.1 in the GDM group and 26.85 ± 4.3 in 
the control group. The difference of 4.16 was statistically confirmed 
as significant for p=0.0006, (Table 1).
Table 1: BMI in GDM and CG.
Groups
Descriptive Statistics  (BMI)
P Value
Mean ± SD Std err Min – MaxGDM 31.01 ± 7.1 0.998 18.7 – 48 t =3.55  p=0.0006 sigCG 26.85 ± 4.3 0.612 21 – 41 
Note: t (Student t-test)
Gestational Weight (Gwg) In Gdm
Pregnant women with GDM had insignificantly more gestational weight gain than the ones without GDM (12.54 ± 4.7 vs 11.44 ± 4.4; p=0.23, Table 2). Pregnant women with GDM more often than the control group gained between 10 and 14 kg – 46% vs 36%. Also, more often they gained more than 15 kg– 36% vs 28%. The 
difference of this distribution was not statistically confirmed as 
significant (p=0.13, Table 3).
Table 2: Gestational weight gain/GWG in GDM and control group.
Groups
Descriptive Statistics  (GWG)
P Value
Mean ± SD Std err Min – MaxGDM 12.54 ± 4.7 0.664 5 – 30 t =1.21  p=0.23 nsCG 11.44 ± 4.4 0.622 3 – 20 
Note: t (Student t-test)
Table 3: Distribution of GWG in GDM and CG.
GWG
Groups
P Value
N GDMn (%)
CG
n (%)
<9 kg 27 9 (18) 18 (36) X2=4.11 p=0.13 ns10 – 14 kg 41 23 (46) 18 (36)> 15 kg 32 18 (36) 14 (28)
Note: p(Chi-square test)
Premature Delivery in Gdm
Pregnant women with GDM significantly more often had premature delivery compared to normoglycemic women (20% vs 4%, p=0.014), Table 4.
Table 4: Distribution of GWG in GDM and CG.
Premature 
delivery
Groups
P Value
N GDMn (%)
CG
n (%)No 88 40 (80) 48 (96) X2=6.06 p=0.014sigYes 12 10 (20) 2 (4)
Note: p(Chi-square test)
Hypertensive Disorders of Pregnancy in GdmIn 26% of pregnant women with GDM vs 6% of the control group hypertensive disorders of pregnancy occurred. Our results 
showed GDM was significantly associated with hypertensive disorders of pregnancy (p=0.0064), Table 5.
Table 5: Hypertensive disorders of pregnancy and GDM.
Hypertensive 
disorders of 
pregnancy
Groups
P Value
N GDMn (%)
Controls
n (%)No 84 37 (74) 47 (94) X2=7.44 p=0.0064 sigYes 16 13 (26) 3 (6)
Note: p(Chi-square test)
Way of Delivery in Gdm
Statistically significantly different was way of delivery in pregnant women with or without GDM (p=0.045). Pregnant women with GDM were delivered more often with caesarean section– 64% vs 44%, or delivery was less likely to be spontaneous– 36% vs 56% (Table 6).
Table 6: Hypertensive disorders of pregnancy and GDM.
Way of 
delivery
Groups
P Value
N GDMn (%)
Controls
n (%)Spontaneous 46 18 (36) 28 (56) X2=4.03p=0.045 sigCaesarean section 54 32 (64) 22 (44)
Note: p(Chi-square test)
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Neonatal Birth Weight and Length in Gdm Minimal neonatal birth weight in GDM group was 1230g vs 1800 g in the control group. Maximal neonatal birth weight was 4470g in GDM group and 4220g in the control group. Average neonatal 
birth weight was 3220.4 ± 784.9h in GDM vs 3290.6 ± 450.9g in the 
control group (Table 7). There was not a significant difference in the birth weight (p=0.58) and in birth length of newborn babies in form both groups (p=0.21). Most probable reason for this outcome is the larger percent of premature deliveries in GDM and smaller birth weight and length of these newborns. Average birth length 
of newborns in GDM group was 49.58 ± 3.3cm, and in groups of 
mothers with negative OGTT was 50.26 ± 1.9cm, (Table 8).
Table 7: Average birth weight in newborns from GDM vs control 
group
Groups
Descriptive Statistics  (Birth weight/ 
gr.) P Value
Mean ± SD Std Err Min – MaxGDM 3220.4 ± 784.9 110.99 1230 – 4470 t =0.55 p=0.58 nsCG 3290.6 ± 450.9 63.76 1800 – 4220 
Note: t (Student t-test)
Table 8: Birth length in newborns from GDM vs CG.
Groups
Descriptive Statistics  (Birth length cm)
P Value
Mean ± SD Std Err Min – MaxGDM 49.58 ± 3.3 0.474 38 – 55 t =1.25  p=0.21 nsCG 50.26 ± 1.9 1.861 44 – 54 
Note: t (Student t-test)
Apgar Score in Newborns from Gdm Vs Normoglycemic 
Women
Table 9: 1st minute Apgar score in GDM and CG.
1st min Apgar 
score
Groups
N GDM n (%) CG n (%)4 1 1 (2) 05 2 2 (4) 06 4 3 (6) 1 (2)7 15 11 (22) 4 (8)8 70 30 (60) 40 (80)
9 8 3 (6) 5 (10)In table distribution of pregnant women with and without GDM in terms of Apgar score 1 minute after birth is shown, (Table 
9). Average 1st minute Apgar score in GDM was 7.52 ± 0.9, and 
was significantly lower than control group, 7.98 ± 1.2, (p=0.04), (Table 10). We compared both groups in terms of value of 1st minute Apgar score smaller and bigger than 7. In the GDM group 12% of the newborns had 1st minute Apgar score smaller than 7 and in the control group than percent was 2%. That difference wasn’t statistically different (p=0.12), (Table 11). In the Table 12 distribution of pregnant women with or without GDM about 
5th minute Apgar score is shown. AS in the 5th minute had lower 
average value in GDM but no statistical significance (8.54 ± 0.9 vs 8.86 ± 1.3; p=0.16), (Table 13). AS lower than 7 in the 5th minute had 2 newborn babies in the GDM group and none in the control group (Table 14).
Table 10: Average 1st minute Apgar score in GDM and CG.
Groups
Descriptive Statistics (AS 1st Minute)
P Value
mean ± SD Median IQRGDM 7.52 ±1.0 8 7 – 8 t =1.43  p=0.04 sigCG 7.98± 1.2 8 7 – 8 
Note: t (Student t-test)
Table 11: 1st minute Apgar score <7 in GDM and control group.
1st minute 
AS
Groups
P Value
N GDMn (%)
CG
n (%)<7 8 6 (12) 1 (2) t =1.25  p=0.21 ns> 7 92 44 (88) 49 (98)
Note: Yates Chi-square test = 2.46 p=0.117
Table 12: 5th minute Apgar score in GDM and CG.
5th minute AS
Groups
N GDM n (%) CG n (%)5 1 1 (2) 06 1 1 (2) 07 5 3 (6) 2 (4)8 18 12 (24) 6 (12)
9 70 31 (62) 39 (78)10 5 2 (4) 3 (6)
Table 13: Average value of 5th minute AS in GDM and control 
group.
Groups
DescriptiveStatistics (5th min)
P Value
Mean ± SD Median IQRGDM 8.54 ± 0.9 9 8 – 10 t =0.78 p=0.16 nsCG 8.86 ± 1.3 9 9 – 10 
Note: t (Student t-test)
Table 14: 5th minute AS in GDM and CG.
5th min AS
Groups
P Value
N ГДМn (%)
КГ
n (%)<7 2 2 (4) 0 p=0.48 ns> 7 98 48 (96) 50(100)
Note: t (Student t-test)
Neonatal Respiratory Distress Syndrome in Gdm Vs 
Control GroupIn our research neonatal respiratory distress syndrome 
was significantly associated with gestational diabetes mellitus 
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(p=0.005). Distribution in Table 15 is presenting 30% of the newborns in GDM and 8% in the control group with RDS, Table 15.
Table 15: Neonatal respiratory distress syndrome in GDM.
RDS
Groups
P Value
N GDMn (%)
CG
n (%)No 81 35 (70) 46 (92) X2=7.86 p=0.005 sigYes 19 15 (30) 4 (8)
Note: Yates Chi-square test = 0.51 p=0.476
Neonatal Hypoglycemia in Gdm Vs Control GroupIn the GDM group neonatal hypoglycemia was registered in 26% 
of the newborns and significantly more rare in control group, 8% of 
the newborns, (Table 16). Neonatal hypoglycemia was significantly associated with GDM (p=0.016).
Table 16: Neonatal hypoglycemia in GDM.
Hypoglycemia
Groups
P Value
N GDMn (%)
CG
n (%)No 83 37 (74) 46 (92) X2=5.74 p=0.016 sigYes 17 13 (26) 4 (8)
Note: p(Chi-square test)
Acid Base Status in Newborns from Gdm Mothers
There was a significant difference in the acid base status of the newborns between women with and without GDM (p=0.027). In 12% of the newborns in GDM group 5 minutes after birth umbilical cord ph <7.25 was measured. In the control group there was no such case, (Table 17).
Table 17: Acid-base status in newborn - ph<7.25 in GDM and 
CG.
ph<7.25
Groups
P Value
N GDMn (%)
CG
n (%)No 94 44 (88) 50 (100) p=0.027sigYes 6 6 (12) 0
Note: p (fisher)
Neonatal Hyperbilirubinemia in Gdm This neonatal outcome was more often in GDM babies (28% vs 
14%) but with no statistical significance (p=0.086, Table 18).
Table 18: Neonatal hyperbilirubinemia and GDM.
Neonatal 
hyperbilirubinemia
Groups
P Value
N GDMn (%)
CG
n (%)No 79 36 (72) 43 (86) X2=2.95 p=0.086 nsYes 21 14 (28) 7 (14)
Note: p(Chi-square test)
Admission of The Newborns from Gdm Mothers in 
Intensive Care UnitIn the GDM group 12% of the newborns were admitted in the intensive care unit whereas in the control group there was no 
such case. This neonatal outcome was statistically significant for 
p=0.027, (Table 19).
Table 19: Admission of the newborns form GDM in ICU.
ICU
Groups
P Value
N GDMn (%)
CG
n (%)No 94 44 (88) 50 (100) X2=2.95 p=0.086 nsYes 6 6 (12) 0
Note: p(Chi-square test)
Neonatal Outcome in Gdm And Normoglycemic WomenThere was a one case of neonatal death from complications related to prematurity, (Table 20).
Table 20: Neonatal death in GDM and control group.
Neonatal death
Groups
N GDM n (%) CG n (%)No 99 49 (98) 50 (100)Yes 1 1 (2) 0
Note: p (fisher)
DiscussionGDM has a growing prevalence worldwide as the prevalence of obesity is growing. The unfavorable perinatal outcome associated with GDM results from the metabolic milieu projected to the fetus through the placenta [1].Women with GDM in our study and according to the studies 
from Catalano и Chu more often were overweight or obese [11,12]. Average BMI was 31.01 ± 7.1 in GDM and 26.85 ± 4.3 in the control group (p=0.0006). Although gestational weight gain 
was not statistically significant in our study, we think that is an important clinical parameter in followment of these patients. Pregnant women with positive OGTT test were referred to endocrinologist for glycemic monitoring and treatment: most of them had diet (n=34, 68%), some had insulin (n=14, 28%) and only 2 had metformin (n=2, 4%). Prenatal care in GDM women was according to the clinical protocol. Deliveries were spontaneous or C section according to the case. There were no cases of vacuum or forceps deliveries and no birth traumatism. GDM is associated to hypertensive disorders of pregnancy. In our study 26% vs 6% in 
the control group, p=0.0064 which confirmed findings of Ross et al. 
[13]. In our study GDM women significantly more had premature 
delivery – 20% vs 4%, p=0.014, similar as findings of Kock et al. [6].There was a one case of cardiopathy in GDM group and one case of neonatal death due to prematurity issues. GDM is associated also 
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with elective or urgent cesarean section [4]. Our results showed 64% incidence in GDM group vs 44% in the control group, p=0.045. Due to prematurity rate in GDM average birth weight in GDM was 
3220.4 g± 784 (1230-4470g) and in the control group 3290.6 g± 450 (1800-4220g). According to our results average 1st minute 
Apgar score in GDM was 7.52 ± 0.9, significantly lower than control 
group- 7.98 ± 1.2 (p=0.04). Jones et al found association between GDM and neonatal respiratory distress, similar as our study [14]. 
Neonatal hypoglycemia according to our results was significantly associated to GDM (26% incidence vs 8% in the control group, p=0.016). Screening for hypoglycemia in all newborns form diabetic mothers should be done in the early neonatal period because of the 
risk for convulsions and poor neurologic [8]. Our findings showed 
significant difference in acid base status between 2 groups of newborns, none of the control group had umbilical artery ph <7.25 vs 12% of GDM group (p=0.027) similar as study of Aalipur et al. [15].
 Paunikare et al. [16] in a study of 900 women, out of which 30 had GDM found that the incidence of neonatal hyperbilirubinemia in GDM mothers was 13%. Our results were 28% in GDM vs 14% in the control group. NICU admission is more often in GDM newborns than in general population. Hakeem et al. [4] found 
incidence of 4.9%, 5.1% in Da Silva et al. [17], 6.7% in Palatnik et al. [18]. Compared to these results we have higher incidence, 12 % (p=0.027) which is because of the higher rate of premature labour in our case, p=0.027. 
Conclusion
There was a significant difference in BMI, hypertensive disorders of pregnancy, preterm labour and cesarean section deliveries between women with GDM vs normoglycemic women. Neonatal respiratory distress, neonatal hypoglycemia, umbilical cord ph <7.25, lower 1st minute Apgar score and NICU admission 
significantly was associated with mothers with GDM. Therefore, adequate prenatal care and treatment of GDM can achieve better maternal and neonatal outcome.
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